These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34445815)

  • 1. [The impact of digoxin on the long-term outcomes in patients with coronary artery disease and atrial fibrillation].
    Qiao Y; Wang Y; Jiang CX; Li SN; Sang CH; Tang RB; Long DY; Wu JH; He L; Du X; Dong JZ; Ma CS
    Zhonghua Nei Ke Za Zhi; 2021 Sep; 60(9):797-805. PubMed ID: 34445815
    [No Abstract]   [Full Text] [Related]  

  • 2. [Association between duration of digoxin use and adverse outcomes among Chinese patients with atrial fibrillation].
    Chang SS; Gao Y; Xia SJ; Du X; Dong JZ; Ma CS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):728-734. PubMed ID: 32957754
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.
    Al-Zakwani I; Panduranga P; Zubaid M; Sulaiman K; Rashed WA; Alsheikh-Ali AA; AlMahmeed W; Shehab A; Al Qudaimi A; Asaad N; Amin H
    J Cardiovasc Pharmacol Ther; 2016 May; 21(3):273-9. PubMed ID: 26341119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.
    Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Behlouli H; Pilote L
    Am J Cardiol; 2014 Aug; 114(3):401-6. PubMed ID: 24950677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin Is Associated With Increased All-cause Mortality in Patients With Atrial Fibrillation Regardless of Concomitant Heart Failure: A Meta-analysis.
    Wang ZQ; Zhang R; Chen MT; Wang QS; Zhang Y; Huang XH; Wang J; Yan JH; Li YG
    J Cardiovasc Pharmacol; 2015 Sep; 66(3):270-5. PubMed ID: 26348825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF).
    Friberg L; Hammar N; Rosenqvist M
    Heart; 2010 Feb; 96(4):275-80. PubMed ID: 19710030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes in patients with atrial fibrillation treated with digoxin, according to the presence of heart failure: Insights from the MISOAC-AF trial.
    Botis M; Kartas A; Samaras A; Akrivos E; Vrana E; Liampas E; Papazoglou AS; Moysidis DV; Papanastasiou A; Baroutidou A; Karvounis H; Tzikas A; Parissis J; Drakos SG; Giannakoulas G
    Hellenic J Cardiol; 2022; 68():25-32. PubMed ID: 36037999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation.
    Pastori D; Farcomeni A; Bucci T; Cangemi R; Ciacci P; Vicario T; Violi F; Pignatelli P
    Int J Cardiol; 2015 Feb; 180():1-5. PubMed ID: 25460369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of digoxin use and risk of mortality in ED patients with atrial fibrillation.
    Wu S; Yang YM; Zhu J; Ren JM; Wang J; Zhang H; Shao XH
    Am J Emerg Med; 2017 Nov; 35(11):1589-1594. PubMed ID: 28551087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Digoxin Use and Adverse Outcomes Among Patients in the Chinese Atrial Fibrillation Registry.
    Gao Y; Chang S; Du X; Dong J; Xu X; Zhou Y; Lip GYH; Ma C
    Am J Cardiovasc Drugs; 2019 Dec; 19(6):579-587. PubMed ID: 31077081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digoxin and mortality in atrial fibrillation: a prospective cohort study.
    Hallberg P; Lindbäck J; Lindahl B; Stenestrand U; Melhus H;
    Eur J Clin Pharmacol; 2007 Oct; 63(10):959-71. PubMed ID: 17684738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin is associated with worse outcomes in patients with heart failure with reduced ejection fraction.
    Zhou J; Cao J; Jin X; Zhou J; Chen Z; Xu D; Yang X; Dong W; Li L; Fan Y; Chen L; Zhong Q; Fu M; Hu K; Ge J;
    ESC Heart Fail; 2020 Feb; 7(1):138-146. PubMed ID: 31994361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-Analysis of Effects of Digoxin on Survival in Patients with Atrial Fibrillation or Heart Failure: An Update.
    Vamos M; Erath JW; Benz AP; Lopes RD; Hohnloser SH
    Am J Cardiol; 2019 Jan; 123(1):69-74. PubMed ID: 30539748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin, mortality, and cardiac hospitalizations in patients with atrial fibrillation and heart failure with reduced ejection fraction and atrial fibrillation: An AF-CHF analysis.
    Elayi CS; Shohoudi A; Moodie E; Etaee F; Guglin M; Roy D; Khairy P;
    Int J Cardiol; 2020 Aug; 313():48-54. PubMed ID: 32320783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.
    Gheorghiade M; Fonarow GC; van Veldhuisen DJ; Cleland JG; Butler J; Epstein AE; Patel K; Aban IB; Aronow WS; Anker SD; Ahmed A
    Eur Heart J; 2013 May; 34(20):1489-97. PubMed ID: 23592708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of digoxin on risk of death in heart failure patients treated with b-blockers. Results from Polish part of ESC Heart Failure Long-Term Registry.
    Migaj J; Kałużna-Oleksy M; Nessler J; Opolski G; Crespo-Leiro MG; Maggioni AP; Grajek S; Ponikowski P; Drożdż J; Straburzyńska-Migaj E
    Kardiol Pol; 2018; 76(7):1064-1072. PubMed ID: 29476617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality in heart failure with atrial fibrillation: Role of digoxin and diuretics.
    Gonzalez-Loyola F; Abellana R; Verdú-Rotellar JM; Bustamante Rangel A; Clua-Espuny JL; Muñoz MA
    Eur J Clin Invest; 2018 Nov; 48(11):e13014. PubMed ID: 30091171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin use and outcomes after myocardial infarction in patients with atrial fibrillation.
    Kytö V; Saraste A; Rautava P; Tornio A
    Basic Clin Pharmacol Toxicol; 2022 Jun; 130(6):655-665. PubMed ID: 35420260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin in patients with permanent atrial fibrillation: data from the RACE II study.
    Mulder BA; Van Veldhuisen DJ; Crijns HJ; Tijssen JG; Hillege HL; Alings M; Rienstra M; Van den Berg MP; Van Gelder IC;
    Heart Rhythm; 2014 Sep; 11(9):1543-50. PubMed ID: 24924587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses.
    Gazzaniga G; Menichelli D; Scaglione F; Farcomeni A; Pani A; Pastori D
    Eur J Clin Pharmacol; 2023 Apr; 79(4):473-483. PubMed ID: 36872367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.